Clinical trial
Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low…
NCT00075387 · OHSU Knight Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00075387 |
|---|---|
| Title | Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors |
| Official title | Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-Arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | Oregon Health and Science University |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Glioma |
| Intervention type | Drug, Other |
| Interventions | Carboplatin, Cyclophosphamide, Etoposide Phosphate, Quality-of-Life Assessment, Sodium Thiosulfate |
| Enrollment | 48 |
| Start date | Mar 7, 2003 |
| Primary completion | Apr 30, 2023 |
| Completion | Apr 30, 2024 |
| First posted | Jan 12, 2004 |
| Last update posted | May 3, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: